These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31482497)

  • 1. Key Physicochemical Characteristics Influencing ADME Properties of Therapeutic Proteins.
    Jing X; Hou Y; Hallett W; Sahajwalla CG; Ji P
    Adv Exp Med Biol; 2019; 1148():115-129. PubMed ID: 31482497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Influencing ADME Properties of Therapeutic Antisense Oligonucleotides: Physicochemical Characteristics and Beyond.
    Jiang R; Hooshfar S; Rebecca Eno M; Yun C; Sonego Zimmermann E; Shinkyo R
    Curr Drug Metab; 2023; 24(7):536-552. PubMed ID: 37076460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption, distribution, metabolism, and excretion (ADME) studies of biotherapeutics for autoimmune and inflammatory conditions.
    Vugmeyster Y; Harrold J; Xu X
    AAPS J; 2012 Dec; 14(4):714-27. PubMed ID: 22798020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Silico Absorption, Distribution, Metabolism, Excretion, and Pharmacokinetics (ADME-PK): Utility and Best Practices. An Industry Perspective from the International Consortium for Innovation through Quality in Pharmaceutical Development.
    Lombardo F; Desai PV; Arimoto R; Desino KE; Fischer H; Keefer CE; Petersson C; Winiwarter S; Broccatelli F
    J Med Chem; 2017 Nov; 60(22):9097-9113. PubMed ID: 28609624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development.
    Tibbitts J; Canter D; Graff R; Smith A; Khawli LA
    MAbs; 2016; 8(2):229-45. PubMed ID: 26636901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and ADME characterizations of antibody-drug conjugates.
    Lin K; Tibbitts J; Shen BQ
    Methods Mol Biol; 2013; 1045():117-31. PubMed ID: 23913144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADME-AP: a database of ADME associated proteins.
    Sun LZ; Ji ZL; Chen X; Wang JF; Chen YZ
    Bioinformatics; 2002 Dec; 18(12):1699-700. PubMed ID: 12490461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical Models to Characterize the Absorption, Distribution, Metabolism, and Excretion of Protein Therapeutics.
    Liu S; Shah DK
    Drug Metab Dispos; 2022 Jun; 50(6):867-878. PubMed ID: 35197311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic considerations for the next generation protein therapeutics.
    Shah DK
    J Pharmacokinet Pharmacodyn; 2015 Oct; 42(5):553-71. PubMed ID: 26373957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption, Distribution, Metabolism, and Excretion of Therapeutic Proteins: Current Industry Practices and Future Perspectives.
    Bolleddula J; Brady K; Bruin G; Lee A; Martin JA; Walles M; Xu K; Yang TY; Zhu X; Yu H
    Drug Metab Dispos; 2022 Jun; 50(6):837-845. PubMed ID: 35149541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Pharmacokinetics of Approved RNA Therapeutics.
    Jo SJ; Chae SU; Lee CB; Bae SK
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of physiochemical properties on pharmacokinetics of protein therapeutics.
    Swami R; Shahiwala A
    Eur J Drug Metab Pharmacokinet; 2013 Dec; 38(4):231-9. PubMed ID: 23584976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-Task ADME/PK prediction at industrial scale: leveraging large and diverse experimentaldatasets.
    Walter M; Borghardt JM; Humbeck L; Skalic M
    Mol Inform; 2024 Jul; ():e202400079. PubMed ID: 38973777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico ADME-Tox modeling: progress and prospects.
    Alqahtani S
    Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1147-1158. PubMed ID: 28988506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research.
    Cronin JM; Yu AM
    Drug Metab Dispos; 2023 Jun; 51(6):685-699. PubMed ID: 36948592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PK/DB: database for pharmacokinetic properties and predictive in silico ADME models.
    Moda TL; Torres LG; Carrara AE; Andricopulo AD
    Bioinformatics; 2008 Oct; 24(19):2270-1. PubMed ID: 18684738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-ADME relationship: still a long way to go?
    Hou T; Wang J
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):759-70. PubMed ID: 18611116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methods.
    Tsaioun K; Blaauboer BJ; Hartung T
    ALTEX; 2016; 33(4):343-358. PubMed ID: 27806179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. truPK -- human pharmacokinetic models for quantitative ADME prediction.
    Subramanian K
    Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):555-64. PubMed ID: 16863461
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.